Key facts
- BlackRock Portfolio Management LLC filed SCHEDULE 13G for LB PHARMACEUTICALS INC Common Stock (LBRX).
- Disclosed ownership: 5.9%.
- Date of event: 30 Sep 2025.
BlackRock Portfolio Management LLC - 30 Sep 2025 SCHEDULE 13G Report for LB PHARMACEUTICALS INC Common Stock (LBRX)
- Filing Manager
- BlackRock Portfolio Management LLC
- Reporting Manager
- BlackRock Portfolio Management LLC
- Security
- LB PHARMACEUTICALS INC Common Stock
- Symbol
- LBRX
- Shares outstanding
- 16,525,424 shares
- Disclosed Ownership
- 975,000 shares
- Ownership
- 5.9%
- Form type
- SCHEDULE 13G
- Filing time
- 17 Oct 2025, 12:45:42 UTC
- Date of event
- 30 Sep 2025
- Next filing
- 21 Jan 2026
- SEC
- View on sec.gov
Key filing fact
BlackRock Portfolio Management LLC disclosed 5.9% ownership in LB PHARMACEUTICALS INC Common Stock (LBRX) on 30 Sep 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Oct 2025, 12:45.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BlackRock Portfolio Management LLC | 5.9% | 975,000 | 874,004 | 0 | Spencer Fleming | Managing Director |
CIK / CUSIP context first